PL409542A1 - Kombinacja i kompozycje farmaceutyczne przeciwko zapaleniu nerwów - Google Patents

Kombinacja i kompozycje farmaceutyczne przeciwko zapaleniu nerwów

Info

Publication number
PL409542A1
PL409542A1 PL409542A PL40954212A PL409542A1 PL 409542 A1 PL409542 A1 PL 409542A1 PL 409542 A PL409542 A PL 409542A PL 40954212 A PL40954212 A PL 40954212A PL 409542 A1 PL409542 A1 PL 409542A1
Authority
PL
Poland
Prior art keywords
neuritis
pharmaceutical combination
compositions against
vitamin
antiepileptic
Prior art date
Application number
PL409542A
Other languages
English (en)
Other versions
PL231163B1 (pl
Inventor
Arroyo Hector Senosiain
Paniagua Maria Angelica Arzola
Original Assignee
Laboratorios Senosiain S.A. De C.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48611941&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL409542(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Senosiain S.A. De C.V. filed Critical Laboratorios Senosiain S.A. De C.V.
Publication of PL409542A1 publication Critical patent/PL409542A1/pl
Publication of PL231163B1 publication Critical patent/PL231163B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Wynalazek dotyczy farmaceutycznej kombinacji dwóch przeciwpadaczkowych substancji jak również kombinacji przeciwpadaczkowego leku i kompleksu witamin B, w której przeciwpadaczkowe substancje są wybrane z pregabaliny i okskarbazepiny, a witaminy są wybrane z witaminy B1 i witaminy B12. Wynalazek dotyczy również kompozycji farmaceutycznych zawierających rzeczone kombinacje i zastosowania wybranych kompozycji do leczenia bólu neuropatycznego.
PL409542A 2011-12-16 2012-12-14 Kombinacja i kompozycja farmaceutyczna do zastosowania w leczeniu i/lub zapobieganiu bólowi z powodu umiarkowanych do ciężkich neuralgii o różnorodnym umiejscowieniu PL231163B1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
MX2011/014042 2011-12-16
MX2011014042A MX336979B (es) 2011-12-16 2011-12-16 Combinacion farmaceutica antineuritica y composiciones.
PCT/IB2012/057345 WO2013088410A1 (es) 2011-12-16 2012-12-14 Combinación farmacéutica antineurítica y composiciones

Publications (2)

Publication Number Publication Date
PL409542A1 true PL409542A1 (pl) 2015-07-20
PL231163B1 PL231163B1 (pl) 2019-01-31

Family

ID=48611941

Family Applications (1)

Application Number Title Priority Date Filing Date
PL409542A PL231163B1 (pl) 2011-12-16 2012-12-14 Kombinacja i kompozycja farmaceutyczna do zastosowania w leczeniu i/lub zapobieganiu bólowi z powodu umiarkowanych do ciężkich neuralgii o różnorodnym umiejscowieniu

Country Status (14)

Country Link
US (1) US20140323428A1 (pl)
BR (1) BR112014014774A2 (pl)
CA (1) CA2859487C (pl)
CL (1) CL2014001581A1 (pl)
CO (1) CO6990712A2 (pl)
CR (1) CR20140283A (pl)
DO (1) DOP2014000134A (pl)
ES (1) ES2525952B1 (pl)
GT (1) GT201400115A (pl)
MX (1) MX336979B (pl)
NI (1) NI201400058A (pl)
PE (1) PE20141688A1 (pl)
PL (1) PL231163B1 (pl)
WO (1) WO2013088410A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2826470B1 (en) * 2013-07-19 2017-09-06 Arven Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of pregabalin
MX2014008336A (es) 2014-07-07 2016-01-07 Pptm Internat S A R L Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2006127475A (ru) * 2003-12-29 2008-02-10 Джейсон МАКДЭВИТТ (US) Композиции и способы лечения рецидивирующих медицинских состояний
JP5452494B2 (ja) * 2007-10-09 2014-03-26 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング ベンフォチアミンと１または２種以上の医薬活性剤とを含む神経因性の疼痛状態の処置のための医薬組成物
US8394759B2 (en) * 2008-11-21 2013-03-12 Cymbiotics, Inc. Transdermal delivery of medicaments with combinations of cetylated fatty ester penetrant complexes

Also Published As

Publication number Publication date
GT201400115A (es) 2017-07-27
US20140323428A1 (en) 2014-10-30
MX336979B (es) 2016-02-09
BR112014014774A2 (pt) 2017-06-13
DOP2014000134A (es) 2014-07-31
CL2014001581A1 (es) 2014-09-26
WO2013088410A1 (es) 2013-06-20
PL231163B1 (pl) 2019-01-31
NI201400058A (es) 2014-12-22
CO6990712A2 (es) 2014-07-10
ES2525952B1 (es) 2015-10-05
CR20140283A (es) 2015-03-11
CA2859487C (en) 2016-11-15
CA2859487A1 (en) 2013-06-20
ES2525952A1 (es) 2015-01-02
PE20141688A1 (es) 2014-12-03
MX2011014042A (es) 2013-06-17

Similar Documents

Publication Publication Date Title
TN2015000278A1 (en) Autotaxin inhibitors
NI201400032A (es) Piridopirazinas anticancerígenas via la
PH12016500094A1 (en) Autotaxin inhibitors
EA201200937A1 (ru) Твердая лекарственная форма тикагрелора
WO2012174158A3 (en) Administration of benzodiazepine
MX2015004604A (es) Antagonistas de los receptores metabotropicos de glutamato 2/3 (mglu2/3) para el tratamiento de los trastornos autistas.
AU2012347200A8 (en) Tablet capable of combatting misuse by injection
PH12014502032A1 (en) Treatment of brain cancer
MX349224B (es) Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa.
UA116889C2 (uk) Фармацевтична композиція, що містить суміш ізоформ apg101 (cd95-fc)
MX357284B (es) Compuestos de quinona para tratar enfermedades mediadas por ape1.
EA201791219A1 (ru) Антибактериальные композиции, имеющие широкий спектр активности
PH12016500124A1 (en) Via antagonists to treat phase shift sleep disorders
MX364528B (es) Witanólidos útiles para el tratamiento de enfermedades neurodegenerativas.
PL409542A1 (pl) Kombinacja i kompozycje farmaceutyczne przeciwko zapaleniu nerwów
IN2014DN03010A (pl)
EP3326628A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION WITH HIGH-CONCENTRATED TAXAN
MX2014004210A (es) Derivados de 2-oxo-piperidinilo.
MX361369B (es) Modificaciones cristalinas estables de cloruro de dotap.
WO2014122671A3 (en) Solid oral compositions of saxagliptin
EP3326652A4 (en) Pharmaceutical composition for oral administration comprising high concentration taxane
MX2014004742A (es) Nuevos agentes antibacterianos de fenicol.
GEP20135745B (en) Drug for pyodermia treatment
UA97054C2 (ru) Способ комплексного лечения больных с зависимостью вследствие употребления психоактивных веществ
PL402030A1 (pl) Nowe pochodne tiosemikarbazonów, ich kompozycje farmaceutyczne oraz ich zastosowanie